Valuation
- Market cap
- 328,061,000
- Revenue TTM
- $1,080,400,000
- Net income TTM
- $95,400,000
- PE ratio
- 2.77
- Forward PE
- 3.08
- Profit margin
- 8.83%
- Debt to equity
- -2.37
Trading
- Volume
- 1,143,200
- Avg volume
- 1,403,402
- Day's range
- $5.49 – $5.82
- Shares out
- 56,660,000
- Stochastic %K
- 45%
- Beta
- 0.84
- Analysts
- Hold
- Price target
- $4.00
Company profile
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was for...
Show more
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
- Industry
- Medical Instruments & Supplies
- Sector
- Healthcare
- Phone
- 862 401 0000
- Website
- https://www.embecta.com
- Address
- 300 Kimball Drive, Suite 300, Parsippany, United States
Latest news
No headlines yet.
